Conceptual Perspectives: Bacterial Antimicrobial Peptide Induction as a Novel Strategy for Symbiosis with the Human Host

Human beta defensins (hBDs) are small cationic peptides, expressed in mucosal epithelia and important agents of innate immunity, act as antimicrobial and chemotactic agents at mucosal barriers. In this perspective, we present evidence supporting a novel strategy by which the oral bacterium induces h...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 9; p. 302
Main Authors Ghosh, Santosh K, Feng, Zhimin, Fujioka, Hisashi, Lux, Renate, McCormick, Thomas S, Weinberg, Aaron
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 26.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human beta defensins (hBDs) are small cationic peptides, expressed in mucosal epithelia and important agents of innate immunity, act as antimicrobial and chemotactic agents at mucosal barriers. In this perspective, we present evidence supporting a novel strategy by which the oral bacterium induces hBDs and other antimicrobial peptides (AMPs) in normal human oral epithelial cells (HOECs) and thereby protects them from other microbial pathogens. The findings stress (1) the physiological importance of hBDs, (2) that this strategy may be a mechanism that contributes to homeostasis and health in body sites constantly challenged with bacteria and (3) that novel properties identified in commensal bacteria could, one day, be harnessed as new probiotic strategies to combat colonization of opportunistic pathogens. With that in mind, we highlight and review the discovery and characterization of a novel lipo-protein, FAD-I ( Associated Defensin Inducer) associated with the outer membrane of that may act as a homeostatic agent by activating endogenous AMPs to re-equilibrate a dysregulated microenvironment. FAD-I has the potential to reduce dysbiosis-driven diseases at a time when resistance to antibiotics is increasing. We therefore postulate that FAD-I may offer a new paradigm in immunoregulatory therapeutics to bolster host innate defense of vulnerable mucosae, while maintaining physiologically responsive states of inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Microbial Symbioses, a section of the journal Frontiers in Microbiology
Edited by: Malka Halpern, University of Haifa, Israel
Reviewed by: Ulvi Kahraman Gürsoy, University of Turku, Finland; Dongbo Sun, Heilongjiang Bayi Agricultural University, China
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2018.00302